Particle Measuring Systems (PMS), a global leader in contamination monitoring, and Pharma Integration, a company that specializes in innovative robotic solutions for small volume fill-finishing for next generation injectable drugs are proud to announce the launch of the BioCapt Single-Use AutoM Microbial Impactor.
Maryland biotech Georgiamune nabs $75M to fund three cancer, autoimmune clinical trials
Maryland biotech Georgiamune emerged Wednesday with a $75 million Series A, clearance to begin its first clinical trial later this year and a board that